Introduction
Populations of hematopoietic cells are precisely regulated through interactions with supporting cells as well as by the action of numerous humoral factors, i.e., hematopoietic cytokines (Arai et al., 1990) . The lifespans of mature hematopoietic cells are generally short, and the proliferation and dierentiation of hematopoietic stem cells constantly replenish the cell population that has been lost from the periphery. In contrast, a rapid expansion of a particular population occurs during in¯ammatory and immunological responses. Such inductive hematopoiesis is mainly controlled by activated T cells through the production of cytokines (Arai et al., 1990) . When the in¯ammatory or immunological response is terminated, expanded cells are quickly eliminated and the hematopoietic system returns to the basal steady-state level. Since the homeostasis of the hematopoietic system is thus dynamically maintained, the destruction of the balance between the production and elimination of hematopoietic cells can result in hematopoietic disorders such as leukemia and anemia (Korsmeyer, 1992; .
Although the promotion of cell proliferation has been believed to be a primary clue for the development of cancer (Anderson et al., 1992; Cantley et al., 1991; Schwab, 1990) , the prevention of cell death is now recognized as an important step of oncogenesis (Hale et al., 1996; . For instance, an aberrant expression of Bcl-2 protein is known to protect cells from death rather than stimulating cell cycle transition (Korsmeyer, 1992) . E2A-HLF fusion protein created by the t(17;19)(q22;p13) translocation prevents hematopoietic cells from apoptosis (Inaba et al., 1996) . A loss of function mutation of NF1, a stimulator of RasGTPase, is associated with JCML (juvenile chronic myelogenous leukemia) (Bollag et al., 1996; Largaespada et al., 1996) , possibly by enhancing the basal activity of the Ras pathway (Largaespada et al., 1996) . Since the cellular proteins described above are often involved in the signal transduction elicited by growthpromoting or survival cytokines, the progression of oncogenesis appears to override normal signaling pathways that control cell viability (Hale et al., 1996; Korsmeyer, 1992) .
We previously reported that interleukin 3 (IL-3) and granulocyte macrophage colony stimulating factor (GM-CSF) stimulate multiple signal transduction pathways through the distinct cytoplasmic domains of the shared signaling receptor (bc) Kinoshita et al., 1995b; Miyajima et al., 1993; Sakamaki et al., 1992; Sato et al., 1993) . The membrane-proximal short region (a.a. 455 ± 544) mediates c-myc induction (Kinoshita et al., 1995b; Sato et al., 1993) as well as the activation of the Jak2-Stat5 pathway (Quelle et al., 1994 ) that leads to the induction of several immediate early genes including pim-1 (Mui et al., 1996) , oncostatin M (Yoshimura et al., 1996) and cis (for cytokine-inducible SH2-containing protein) (Yoshimura et al., 1995) . The membrane distal region which lies in the middle of the cytoplasmic domain of bc is necessary for the activation of the Ras pathway (Sato et al., 1993) . Truncation of the distal region of bc abolishes the GM-CSF-induced Ras activation as well as apoptosis prevention. In con-trast, genistein suppresses c-myc induction by GM ± CSF, while it has no eect on Ras activation or apoptosis prevention (Kinoshita et al., 1995b) . Interestingly, activation of the Ras pathway by the expression of a constitutive active form of Ras (RasG12V) completely prevents apoptosis in IL-3-dependent cells. Furthermore, the combination of Ras(G12V) and signal from the truncated GM ± CSF receptor cooperatively stimulated the long-term proliferation of IL-3-dependent cells, suggesting that the Ras pathway is an important component of cell survival signal elicited by IL-3/GM ± CSF in hematopoietic cells (Kinoshita et al., 1995b) .
The Ras pathway was believed to be a linear signaling cascade leading to the sequential activation of Raf, MEK and p42/p44MAPK (Bollag and McCormick, 1991) . However, recent studies have shown that downstream pathways of Ras are highly divergent in mammalian cells (Feig, 1993; McCormick, 1995) . In addition to the Raf/MAPK pathway, some small GTP-binding proteins are implicated in Rasinduced cellular transformation (Downward, 1992; Khosravi-Far and Der, 1994) . For instance, the expression of constitutively active Rac or Rho in rodent ®broblasts induced cellular responses similar to those of Ras(G12V) (Olson et al., 1995; Qiu et al., 1995a,b) . Dominant inhibitory mutants of Rac, Rho and Ral inhibited Ras-induced transformation Qiu et al., 1995b) , suggesting the critical involvement of these proteins in Ras signaling. Analyses of molecules that directly interact with Ras identi®ed several candidate Ras eectors, such as phosphatidyl inositol 3' kinase (PI3K) (RodriguezViciana et al., 1994) and RalGDS (Hofer et al., 1994; Kikuchi et al., 1994; Spaargaren and Bischo, 1994) , which are apparently independent of the Raf/MAPK signaling pathway. Furthermore, there is increasing evidence for other possible eectors of Ras (e.g., MEK kinase 1 and AF6/Rsb1) (Kuriyama et al., 1996; Russell et al., 1995) , indicating that Ras functions as a molecular switch for multiple downstream targets. However, the biological signi®cance of each eector and downstream cascade remains to be elucidated.
In this study, we investigated which downstream pathway of Ras plays a critical role in hematopoietic cell survival. Various Ras mutants that carry a mutation in addition to the oncogenic one were expressed in IL-3-dependent cells, and the correlation between the activation of downstream pathways and anti-apoptotic capability was examined. In addition, we evaluated the eects of putative Ras-eector molecules on cell survival by expressing their constitutively active forms. Our results suggest that the Raf/MAPK pathway and a rapamycin/wortmannin-sensitive pathway (which is likely the PI3K/S6K-dependent) mediate apoptosis prevention by Ras in IL-3-dependent hematopoietic cells.
Results

Characterization of the Ras mutants
We generated various oncogenic Ha-Ras mutants with an additional point mutation in the eector and activator regions of Ras (Akasaka et al., 1996; Shirouzu et al., 1992 Shirouzu et al., , 1994 which is conserved among all members of the Ras-related protein family (Marshall, 1993) . Similar approaches have been adopted by several researchers to investigate the mechanisms of cellular transformation White et al., 1995) , neuronal dierentiation (Shirouzu et al., 1992) and membrane ruing (Joneson et al., 1996) .
Of the mutants analysed in this study, the three Ras(G12V)-type derivatives (G12V/T35S, G12V/D38N and G12V/V45E) were chosen for further characterization because of their distinct properties. All mutants and parent Ras(G12V)-type cDNAs were linked to pMAM-Neo vector (Clontech) in which protein expression is inducible by glucocorticoid (dex) stimulation, and stable transfectants of each mutant were established in IL-3-dependent Ba/F3 cells. Dex addition (2610 77 M) clearly induced transgene expression within several hours, as determined by Western blot analysis using a mAb against c-Ha-Ras (Figure 1 ). We then assessed in transfectants whether the dex addition induces the phosphorylation of MAPK and p70/S6 kinase (S6K) which are downstream targets of Ras (Bourne et al., 1990; Kaziro et al., 1991) . Since those proteins are known to require phosphorylation for their kinase activity, the mobility shift caused by the phosphorylation is generally considered to be a sign of activation of the pathway that includes each kinase. When Ras(G12V) expression was induced in Ba/F3 cells in the absence of IL-3, both MAPK and S6K were phosphorylated within a few hours, suggesting that both MAPK and S6K pathways are activated by Ras(G12V) (Figure 2 ). We also tested the interaction between Ras and the phosphatidyl inositol 3'-kinase (P13K) catalytic subunit, p110 (Rodriguez-Viciana et al., 1994) , and found that Ras(G12V) forms a stable complex with p110 ( Figure 3 ). As shown in Figure 2 , the expression of the Ras(G12V/T35S) mutant, in which Thr-35 is replaced with serine, gave rise to the phosphorylation of MAPK, whereas it failed to phosphorylate S6K. This result indicates that Ras(G12V/T35S) retains the capability to activate the Raf/MAPK pathway in hematopoietic cells, which is consistent with the observation shown in ®broblasts . We noted, however, that the level of MAPK phosphorylation was somehow less than that produced by Ras(G12V). In contrast, Ras(G12V/V45E) did not cause any detectable phosphorylation of MAPK, while it did phosphorylate S6K. Mutation at the 38th residue from aspartic acid to asparagine abolished both activities. In addition, Ras(G12V/V45E), but neither Ras(G12V/T35S) nor Ras(G12V/D38N), was able to form a complex with p110 in a GTP-dependent manner (Figure 3 ), in accord with its ability to phosphorylate S6K. Since S6K is one downstream target of PI3K, the Ras-dependent PI3K/ S6K pathway appears to be activated by the Ras(G12V/V45E) mutant. Thus, Ras(G12V/T35S) and Ras(G12V/V45E) mutants exhibit reciprocal functions in activating MAPK and S6K pathways.
Anti-apoptotic potential of Ras mutants in hematopoietic cells
We previously reported that Ras(G12V) completely blocks apoptosis of IL-3-dependent Ba/F3 and 32D cells without inducing signi®cant cell proliferation (Kinoshita et al., 1995a,b) . Since the expression of oncogenic Raf has been shown to prevent apoptosis in IL-3-dependent cell lines (Cleveland et al., 1994; McCormick, 1995; Troppmair et al., 1992) , we ®rst presumed that the anti-apoptotic eect of Ras is mediated by the Raf/MAPK pathway. However, the identi®cation of multiple eectors of Ras prompted us to examine whether the Raf/MAPK pathway is a single pathway responsible for the suppression of apoptosis. We therefore tested the capability of each Ras(G12V) derivative to inhibit the apoptotic death following IL-3 withdrawal. Ba/F3 transfectants expressing parental Ras(G12V) or the three derivatives were deprived of IL-3 and stimulated with dex (2610 77 M), and transient and long-term cell survival were assessed by DNA fragmentation analysis and trypan blue dye exclusion (Figures 4 and 5 were deprived of IL-3 for 2 h and stimulated with dexamethasone (dex). As a positive control, each transfectant was stimulated with IL-3 for 5 min (for MAPK) or 15 min (for S6K). At the indicated time points, cells were lysed with buer containing phosphatase-and protease inhibitors. Lysates were loaded onto SDS ± PAGE, transferred to a nitrocellulose membrane and probed with anti-MAPK or anti-S6K. The phosphorylated (activated) form of each kinase showed slower mobility than those of the underphosphorylated forms on SDS ± PAGE. As for S6K, three shifted bands were detected; the top band is thought to be the activated S6K
Figure 3 Interaction of Ras mutants with the catalytic subunit of PI3K, p110. The in vitro association between Ras mutants and GST-p110 was investigated. Bacterially produced GST-p110 were incubated with the Ras proteins either in GDP-(D) or GTPbound (T) form in vitro and precipitated on a Glutathione Sepharose column. Samples were separated on SDS ± PAGE and then probed with anti-Ras antibody. Ras(G12V/V45E) migrates slower than other mutants on SDS ± PAGE. Although Ras(G12V/ T35S) had basal binding activity to p110 in the GDP-bound form, the amount of the p110/Ras complex was not augmented in the GTP-bound form Figure 4 Inhibition of DNA fragmentation by expression of Ras mutants. Transfectants were deprived of IL-3, and dex was added to the culture media to induce Ras proteins. After 24 h incubation without IL-3, small chromosomal DNA fragments were puri®ed as described in Materials and methods, and loaded onto 1.5% agarose gel. All transfectants underwent apoptosis in the absence of both IL-3 and dex and subsequent death; however, the anti-apoptotic eect of Ras(G12V/T35S) mutant was not as strong as expected despite its capability to activate MAPK. The weak anti-apoptotic activity probably arose from the weak and transient activation of MAPK by Ras(G12V/T35S) mutant in comparison with that by Ras(G12V) (Figure 2 ). Using an in vitro kinase assay, we observed that MAPK activation by Ras(G12V/ T35S) declined to the basal level after 12 h dex stimulation, whereas Ras(G12V) kept activating MAPK (data not shown). In addition, the expression of oncogenic Raf, which more strongly activated MAPK than did Ras(G12V/T35S) in Ba/F3 cells, inhibited apoptosis more eectively than did Ras(G12V/T35S) upon IL-3 removal ( Figure 6 ). Therefore, we conclude that the Raf/MAPK pathway has an anti-apoptotic potential on its own. Surprisingly, the Ras(G12V/V45E) mutant, which apparently lacks the capability to activate the MAPK pathway, showed a powerful anti-apoptotic eect; DNA fragmentation at 24 h after IL-3 depletion was clearly blocked by Ras(G12V/V45E), and more than 70% of the cells were viable even after 5 days of incubation without IL-3 (Figures 4 and 5 ). The Ras(G12V/D38N) mutant, which is defective in both MAPK and S6K phosphorylation, did not inhibit apoptosis in the absence of IL-3 at all.
Expression of active downstream molecules in IL-3-dependent cells
We took another approach to directly address the antiapoptotic function of downstream pathways. Several possible Ras-target proteins, including those that were shown to participate in cellular transformation in ®broblasts, were introduced into Ba/F3 cells, and cell viability after IL-3 removal was measured ( Figure 6 ). Control cells died rapidly in the absence of IL-3; the percentage of viable cells dropped to less than 10% at 24 h and 0% at 48 h after IL-3 withdrawal. In contrast, the cells expressing N-terminal truncated Raf (DRaf) were highly resistant to IL-3 depletion; more than 60% of the cells were viable after 48 h incubation without IL-3. The level of apoptosis inhibition was similar to that caused by the expression of Bcl-2; however, the protection by DRaf was not as complete as that by Ras(G12V), despite its ecient activation of MAPK (data not shown). Constitutively active forms of other putative downstream molecules including Rho, Ral and Cdc42 were also expressed ( Figure 6 ). None of these was capable of inhibiting apoptosis caused by IL-3 deprivation in Ba/ F3 cells. In addition, the expression of the dominant interfering Rho did not aect the IL-3-induced cell survival or proliferation in Ba/F3 cells (data not shown).
Since Ras (as well as Rho and Cdc42) has been shown to activate JNK in rodent ®broblasts (Coso et al., 1995; Khosravi-Far et al., 1996; Minden et al., 1995; Westwick et al., 1994) , we tested whether JNK is activated by Ras(G12V) in IL-3-dependent cells (Figure 7) . Although IL-3 strongly activated JNK within 10 min, the expression of Ras(G12V) by dex did not up-regulate JNK activity. This result suggests that JNK activity is not necessary for Ras function in preventing apoptosis.
Cell survival mediated by Ras(G12V/V45E) is inhibited by rapamycin or wortmannin
Although Ras(G12V/V45E) was incapable of activating the signaling pathway involving MAPK, Ras(G12V/ V45E) eectively prevented apoptosis following IL-3 deprivation (Figures 4 and 5) . We therefore investigated how Ras(G12V/V45E) mediates cell survival in Ba/F3 cells. Since Ras(G12V/V45E) induced the phosphorylation of S6K (Figure 2 ) and was able to associate with PI3K/p110 (Figure 3) , we speculated that the PI3K/S6K pathway is activated by Ras(G12V/ V45E). It has been suggested that the PI3K pathway plays an important role in suppressing apoptosis in nerve growth factor (NGF)-dependent PC12 cells (Yao and Cooper, 1995) as well as in hematopoietic cells, the survival of which is maintained by IL-4 (Scheid et al., 1995) . These observations led us to consider that the PI3K/S6K pathway might be implicated in the cell survival mediated by Ras(G12V/V45E). To test this possibility, we utilized speci®c inhibitors of the PI3K/ S6K pathway, i.e., wortmannin and rapamycin. As described in Materials and methods, we titrated these inhibitors to avoid the non-speci®c cytotoxicity of these drugs and found that 100 nM wortmannin and 10 ng/ ml rapamycin speci®cally inhibit the S6K phosphorylation without aecting the MAPK phosphorylation induced by either IL-3 or Ras(G12V) expression. We then examined the eects of these inhibitors on cell survival exerted by Ras(G12V) or Ras(G12V/V45E) mutant (Figure 8 ). Upon the induction of Ras(G12V) expression by dex, cells were completely protected from apoptosis in the absence of IL-3 and stayed viable for 4 days without IL-3. Neither wortmannin nor rapamycin inhibited Ras(G12V)-induced cell survival. In contrast, the treatment of Ras(G12V/V45E) transfectant with rapamycin or wortmannin severely damaged cells. In the absence of inhibitor, Ras(G12V/V45E) blocked DNA fragmentation after IL-3 deprivation, while both wortmannin and rapamycin interfered with the antiapoptotic eect of Ras(G12V/V45E), resulting in the fragmentation of chromosomal DNA (Figure 8a) . Furthermore, the cells gradually lost viability, and the percentage of viable cells decreased to less than 10% after 4 days of incubation with dex plus rapamycin (Figure 8b ).
Discussion
The Ras protein is implicated in a number of cellular physiological processes including cell proliferation and dierentiation (Bollag and McCormick, 1991; Bourne et al., 1990; Kaziro et al., 1991; Khosravi-Far and Der, 1994) . During those biological processes, Ras plays important roles in the organization of cellular architecture and regulation of membrane dynamism in addition to cell cycle control. Interestingly, Ras was recently shown to participate in the process of apoptosis, apparently contradicting its oncogenic potential in mammalian cells (Chen and Faller, 1995) . The above pleiotropic functions of Ras are now explained by its capability to activate multiple downstream pathways, mostly through direct interaction with eector proteins such as Raf (Koide et al., 1993; Moodie et al., 1993; Van Aelst et al., 1993 , 1994 Vojtek et al., 1993) and PI3K (Rodriguez-Viciana et al., 1994) . The discovery of putative eector molecules has indicated that Ras functions as a molecular switch in activating downstream pathways (Feig, 1993; Marshall, 1993; Van Aelst et al., 1994) .
Having shown previously that the Ras pathway is an important component of IL-3/GM-CSF signal transduction in preventing apoptosis (Kinoshita et al., 1995b) as well as in up-regulating Bcl-2 family molecules (Kinoshita et al., 1995a) , we investigated which downstream pathway(s) of Ras is responsible for cell survival. Several Ras(G12V) mutants (G12V/T35S, G12V/D38N, G12V/V45E), that mediate the partial signals of Ras (Akasaka et al., 1996; Shirouzu et al., 1992 Shirouzu et al., , 1994 , were utilized to examine the correlation between the biochemical properties and biological functions of the mutants. In IL-3-dependent hematopoietic cells, Ras(G12V) completely blocked apoptosis following IL-3-deprivation and was capable of activating both the MAPK pathways and S6K pathway. One mutant (G12V/T35S) which activates the MAPK pathway inhibited apoptosis following IL-3 withdrawal to some extent, and the expression of DRaf, an activator of MAPK, also blocked apoptosis, indicating that the Raf/MAPK pathway has an antiapoptotic potential on its own in IL-3-dependent cells. Interestingly, Ras(G12V/V45E) mutant defective in activating the MAPK pathway blocked apoptosis eciently in IL-3-dependent cells as well. These results suggest that while the Raf/MAPK pathway alone can prevent apoptosis without activation of an additional signaling pathway, it is not an absolute requirement for hematopoietic cell survival. Above observations raised the interesting question of how Ras(G12V/V45E) prevents apoptosis in IL-3-dependent cells. Since it phosphorylated S6K and was able to form a stable complex with PI3K/p110 (Figures  2 and 3) , the Ras-dependent PI3K/S6K pathway appears to be activated by Ras(G12V/V45E). We therefore examined the role of the PI3K pathway in Ras(G12V/V45E)-mediated cell survival. As shown in Figure 8 , the cells expressing Ras(G12V) were highly resistant to the inhibitors in the absence of IL-3, while rapamycin (and wortmannin to a lesser degree) severely damaged Ras(G12V/V45E)-expressing cells. This result indicates that a rapamycin-sensitive pathway plays an essential role in the anti-apoptotic function of Ras(G12V/V45E), although this pathway is not no factor Dex Dex+WM Dex+Rap marker IL-3 no factor Dex Dex+WM Dex+Rap RasV12 V45E a b Figure 8 Inhibition of Ras(G12V/V45E)-mediated cell survival by rapamycin or wortmannin. The eects of these inhibitors on short-term and long-term cell survival were tested by DNA fragmentation analysis and dye exclusion assay, respectively. These experiments were performed under serum-free conditions because cells sometimes acquired an adhesive property during the experiment in the presence of serum, making it dicult to score the proper rate of cell death. Cells were deprived of IL-3 and stimulated with dex plus either rapamycin (10 ng/ml) or wortmannin (100 nM). After 24 h incubation without IL-3, small chromosomal DNA fragments were puri®ed and analysed by agarose gel electrophoresis (a). Cell viability was also monitored over a 4 day incubation by dye exclusion assay (b), showing that Ras(G12V/V45E)-mediated survival was severely aected by rapamycin and by wortmannin. We noted from microscopic observation that the presence of serum retarded the lethal eect of rapamycin to some extent. However, most Ras(G12V/V45E) cells eventually died even when serum was present, while Ras(G12V) cells did not (data not shown) absolutely necessary for Ras(G12V) function. Thus, two distinct and independent pathways appear to mediate the Ras-induced prevention of apoptosis in hematopoietic cells. A rapamycin-sensitive pathway is likely to involve S6K, since rapamycin speci®cally inhibits the phosphorylation and activation of S6K in various cell types (Kuo et al., 1992; Terada et al., 1992) . However, recent evidence pointed out a potential role of c-Akt serine/ threonine kinase rather than S6K in the prevention of apoptosis in ®broblasts (Kaumann-Zeh et al., 1997; Kulik et al., 1997) and neuronal cells (Dudek et al., 1997) , because the expression of the normal Akt protein or in the oncogenic form (i.e., gag-Akt) signi®cantly enhanced cell survival. Furthermore, rapamycin was shown not to aect cell survival mediated by the P13K pathway in these cells (Dudek et al., 1997; Kaumann-Zeh et al., 1997; Yao and Cooper, 1996) . In contrast, critical in¯uence of rapamycin on hematopoietic cell proliferation and survival has been demonstrated (Gottschalk et al., 1994; Muthukkumar et al., 1995) ; for example, rapamycin enhanced the sensitivity to the apoptotic signal induced by IL-2 deprivation, glucocorticoid or T cell receptor ligation in T cells and by the alkylating reagent, cisplatin, in human leukemic cells (Shi et al., 1995) . We consider that our ®ndings speci®cally highlight the molecular basis of the distinguished sensitivity of hematopoietic cells to rapamycin. Presumably, both the c-Akt and S6K pathways are potentially anti-apoptotic, and the dierences observed between hematopoietic cells and the other cell types may be due to a divergent network of signal transduction pathways in dierent cell types.
The expression of oncogenic Raf alone was sucient to confer the anti-apoptotic potential to hematopoietic cells. In contrast, other signaling proteins in active forms, i.e., Rho, Cdc42 and Ral did not show any detectable anti-apoptotic activity in IL-3-dependent cells, although constitutively activated Rho causes cellular transformation in ®broblasts (Downward, 1992; Olson et al., 1995; Prendergast et al., 1995; Qiu et al., 1995b) . Since the major role of Rho and its related proteins is associated with the regulation of cytoskeletal organization, activation of the Rho pathway alone might be less oncogenic or anti-apoptotic in hematopoietic cells. The JNK/SAPK pathway, another putative downstream target of the Ras pathway Khosravi-Far et al., 1996; Minden et al., 1995; Westwick et al., 1994) , is unlikely to be involved in the Ras-mediated cell survival in IL-3-dependent cells, as JNK activity was not up-regulated by the expression of Ras(G12V) (Figure 7) . Nonetheless, IL-3 stimulation clearly induced JNK activation in Ba/F3 cells; therefore, the JNK pathway is involved in certain IL-3-induced cellular responses which may not be required for cell survival. These contradicting results again suggest the diversity of intracellular signaling between dierent types of cells.
Cell survival is a cumulative event of multiple distinct biological processes, including cell cycle regulation Harrington et al., 1994) , maintenance of cellular metabolism and production of energy (e.g., ATP) (Whetton et al., 1984; Whetton and Dexter, 1983) . It is likely that multiple survival signals dierentially mediate these processes.
We speculate that the Raf/MAPK pathway and a rapamycin/wortmannin-sensitive pathway exert antiapoptotic potentials by stimulating dierent survival mechanisms, and accordingly the inhibition of either pathway (mechanism) may increase the sensitivity of cells to apoptotic signal(s). The Ras protein might elicit synergistic or additive actions of both pathways, thereby exerting complete suppression against apoptotic signal in hematopoietic cells (Kinoshita et al., 1995a,b) . The next question would be what biological process(es) each pathway directly controls under physiological and pathological conditions.
Materials and methods
Cell lines and cell culture
The mouse IL-3-dependent cell line, Ba/F3 was used in the present experiments. Stable transfectants of Ras mutants and signaling proteins were established in Ba/F3 cells as described previously (Kinoshita et al., 1995b) . Transfectants were maintained in growth medium with 1 mg/ml G418. We repeated most experiments using another IL-3-dependent cell line, 32D, and found that our data are basically reproducible in both cell lines. Normally growing cells were cultured in RPMI1640 with 10% fetal calf serum (FCS), 50 mM 2-mercaptoethanol, antibiotics and the mouse IL-3 expressed in silkworms (Miyajima et al., 1987) . To deplete IL-3, cells were washed twice with either IL-3-free growth medium or complete serum-free medium (Kinoshita et al., 1995b) for an appropriate period. The complete serum-free medium was composed of a 1:1 mixture of RPMI1640 and IMDM supplemented with 50 mg/ml human transferrin (Boehringer), 50 mM 2-mercaptoethanol, 30 ng/ml linoleic acid, 1 mM sodium pyruvate, 5 mM glutamic acid, 0.1% bovine serum albumin (BSA; cell culture grade) (Sigma) and the essential lipid solution (0.08 ml/1 ml of medium). The lipid solution was prepared as follows: 20 mg L-aphosphatidylcholine (Sigma; type II-S from soybean) and 12 mg of cholesterol were dissolved in 200 ml of chloroform, and the solution was transferred to a small¯ask to allow complete desiccation for several hours in a draftchamber. Ten ml of a-MEM (NaHCO 3 -free) containing 1% BSA (fatty acid-free) was added to the¯ask, which was then sonicated for 30 min. Insoluble precipitate was removed by centrifugation and ®ltration.
Detection of phosphorylation of MAPK and p70/S6K
The phosphorylation of MAPK and S6K were assessed by the mobility shift on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS ± PAGE) (Alessi et al., 1995) . Ba/F3 cells (10 6 cells) were deprived of IL-3 for 2 h and stimulated with dexamethasone (dex) (2610 77 M). Cells were lysed with 100 ml of lysis buer containing 1% Triton-X100, Tris-HCl (pH 7.2), 150 mM NaCl, 30 mM Na-pyrophosphate, 50 mM NaF, 1 mM Na-orthovanadate and protease inhibitors. After 45 min of gentle agitation at 48C, insoluble materials were cleared by centrifugation (15000 r.p.m., 48C, 10 min). An aliquot of each sample was loaded onto an SDS ± PAGE system followed by Western blotting using speci®c antibodies against c-Ha-Ras (Santa Cruz Biotech), p42/ p44MAPK (Zymed) or p70/S6K (Santa Cruz).
DNA fragmentation analysis
Small fragments of chromosomal DNA were puri®ed as previously described (Kinoshita et al., 1995b) . Brie¯y, 5610 6 cells were lysed with 600 ml of buer (10 mM TrisHCl [pH 7.5], 10 mM EDTA and 0.2% Triton X-100) and incubated on ice for 10 min. Insoluble materials were precipitated by centrifugation (15 000 r.p.m., 48C, 10 min). The supernatant was then subjected to twice extraction with phenol/chloroform/isoamylalchohol (25:24:1) followed by ethanol precipitation. The pellet was dissolved in 20 ml of TE containing 2 mg/ml of RNaseA and incubated at 378C for 30 min. An equal volume of each sample was loaded onto a 1.5% agarose gel for electrophoresis and fragmented DNA was visualized by ethidium bromide staining.
Analysis of physical interaction between Ras and P13K/p110
The Ras(G12V) and mutant Ras proteins were bacterially expressed and puri®ed as previously described (Akasaka et al., 1996) . The GST-PI3K (amino acids 127 ± 356) protein, produced by E. coli (BL21 strain) was puri®ed by using a Glutathione-Sepharose 4B column (Pharmacia) according to the manufacturer's instructions. One mg of GST-PI3K and 0.5 mg of each Ras protein in either GDP-or GTPgS form were incubated for 1 h at 48C in a reaction buer
